Can Rhu Duk-hee retake the helm of KPMA?

Published: 2012-01-06 06:57:00

Updated: 2012-01-06 06:57:00

Keen attention has been paid to the re-appointment of Rhu Duk-hee, incumbent chairman of the Korea Pharmaceutical Manufacturers Association and chairman of Kyungdong Pharmaceutical Co.

According to industry observers, Rhu is likely to be renamed as the KPMA’s chairman as some executives at an ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK